Clinical trial
An Open-Label Study of Donidalorsen in Pediatric Patients Age 2 to Less Than 12 Years Old With Hereditary Angioedema
NCT07298447 is registered in ClinicalTrials.gov with Ionis Pharmaceuticals, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open-Label Study of Donidalorsen in Pediatric Patients Age 2 to Less Than 12 Years Old With Hereditary Angioedema
- Lead sponsor
- Ionis Pharmaceuticals, Inc.
- Phase
- Phase 3
- Overall status
- Recruiting
- Start date
- April 21, 2026
- Completion date
- June 30, 2029
- Enrollment
- 20 (estimated)
- Sites
- 16
Conditions
As the registry lists them; a condition with its own page is linked.
hereditary angioedema (hae)